Form 8-K - Current report:
SEC Accession No. 0001193125-24-286917
Filing Date
2024-12-30
Accepted
2024-12-30 17:20:29
Documents
15
Period of Report
2024-12-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d834253d8k.htm   iXBRL 8-K 22971
2 EX-99.1 d834253dex991.htm EX-99.1 8424
6 GRAPHIC g834253g1231022334258.jpg GRAPHIC 4960
  Complete submission text file 0001193125-24-286917.txt   160008

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cort-20241230.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20241230_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20241230_pre.xml EX-101.PRE 10813
18 EXTRACTED XBRL INSTANCE DOCUMENT d834253d8k_htm.xml XML 3539
Mailing Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065
Business Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 241590609
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)